Trulieve Cannabis (CSE: TRUL) has closed its previously announced marketed public offering of shares, the first such offering available in the United States. The financing saw the firm raise gross proceeds of C$287.5 million.
The financing saw a total of 5.8 million subordinate voting shares of the issuer sold at a price of $50 per share, which includes the full exercise of the over-allotment option. No warrants were issued in connection with the financing.
Proceeds from the offering are to be used to fund business development as well as for general working capital purposes.
Sponsored · Antimony Resources
Trulieve Cannabis last traded at $50.36 on the CSE.
Information for this briefing was found via Sedar and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
